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Background and Objective: Chlorella vulgaris is a multi-cellular edible algal 
species with abundant proteins. Extraction of high value protein fractions for 
pharmaceutical and nutritional applications can significantly increase the 
commercial value of microalga biomasses. There is no known report on the 
anticancer peptides derived from the Chlorella vulgaris abundant protein.  
 
Materials and Methods: This study examined the antimicrobial and anticancer 
effects of peptides from a hydrolyzed Chlorella vulgaris protein with 62 kDa 
molecular weight. Protein hydrolysis was done by pepsin as a gastrointestinal 
protease, and was monitored through protein content measurement, sodium 
dodecyl sulfate polyacrylamide gel electrophoresis, and high performance liquid 
chromatography measurements. Inhibitory effect of the produced peptides on 
Escherichia coli cells and breast cancer cell lines was assayed.  
 
Results and Conclusion: Hydrolyzed peptides induced a decrease of about 
34.1% in the growth of Escherichia coli, and the peptides of 3 to 5 kDa 
molecular weight had strong impact on the viability of breast cancer cells with 
IC50 value of 50 μg μl
-1
. The peptide fractions demonstrating antimicrobial and 
anti-cancer activities have the potential for use as functional food ingredients 
for health benefits. These results demonstrate that inexpensive algae proteins 
could be a new alternative to produce anticancer peptides.  
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Microalgae with mostly as small as about 3-20 
m cells are from the primitive simple organized 
members of the plant kingdom. These algae are 
ubiquitous in nature to the extent that aquatic micro-
algae have been found in the extreme conditions 
from hot springs to glacial ice flows. Being photo-
synthetic and constituting the basis of the marine 
food chain, these microorganisms play a key role in 
the oceans’ productivity [1]. In recent years micro-
algae biotechnology has attracted an increasing 
interest for obtaining foods and biomolecules, com-
prising proteins, vitamins, pigments, polyunsatur-
ated fatty acids, and substances with pharmaceutical 
 
activities [2-4]. There is also a constant demand for 
proteinaceous food materials and single cell protein 
production [5]. Microalgae proteins are among the 
most favorable protein sources in foods due to their 
particular amino acids’ composition necessary for 
numerous biological and physiological functions 
[6]. Since over 50% of most microalgae biomasses 
are composed of proteins, these macromolecules 
appear to play an important role in these green 
plants [7]. Because of their richness and amino acid 
profiles, microalgae proteins have been considered 
as alternative protein sources in foods [8,9], 
however, the food application of microalgal proteins 
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has not achieved significant importance because 
non-protein components lead to undesired changes 
in color, taste, and structure [10]. To increase 
potential food applications and commercial values, 
microalgae proteins have to be isolated with intact 
molecular structure and without any intense color 
and taste [11]. 
As there is a strong relationship between diet and 
health, food is a very vital factor for our health. 
Functional foods have positive physiological effects 
on health, and decrease the risk of diseases. Some 
natural biologically active ingredients (i.e. anti-
oxidant, antiviral and antihypertensive), extracted 
from microalgae, are in great attention in food 
science and technology [12-15]. Microalgal extracts 
are crucial components of functional foods because 
they are considered as natural bioactive ingredients. 
In this regard, extracts from Chlorella species can be 
added to functional foods due to the antioxidant, 
antimicrobial, anti-inflammatory and antiviral prop-
erties of bioactive compounds [1,16]. 
Recently, cancer has turned into the largest 
single cause of death in the world, and chemo-
prevention has been a promising anticancer 
approach along with reducing the morbidity and 
mortality of cancer [17]. A variety of natural comp-
ounds have been shown to be beneficial for the 
inhibition of cancer, such as flavonoids, phenolic 
acids, carotenoids, etc. [18]. Peptides from the 
enzymatic hydrolysis of various food proteins exert 
quite different bioactivities; however, there are few 
publications on anticancer peptides. Some natural 
and synthetic peptides have been reported to show 
anticancer activities. A polysaccharide peptide 
extracted from mushroom showed antitumor activit-
ies. Dolostatins 10 and 15 are peptides isolated from 
marine sea hare Dolabella auricularia known to 
have antitumor activities on several cancer cell 
lines. Several Numerous antimicrobial peptides 
isolated from African frog, Streptomyces, and 
Micromonospora have both antimicrobial and 
anticancer activities [19]. Marine proteins enjoy 
wide sources and abundant content; therefore, activ-
ated peptides from marine food have been gaining 
attention in the past few years. The applications of 
microalgae are as nutritional supplements, natural 
dyes, and skin care products but there is no study 
reporting the anticancer activity of microalgae 
protein derived peptides.  
C. vulgaris is an unicellular green algae found in 
both fresh and marine waters, and are widely used 
as a food supplement throughout the world [20]. The 
nutritional value of C. vulgaris was initially deter-
mined in the 1950s and 1960s [21]. This organism is 
a valuable source of nutrients with significant 
physiological and biochemical attributes, and has a 
relatively low cellulose content [22]. Various benef-
icial effects of C. vulgaris have been reported (e.g., 
prevention and treatment of cancer, as well as 
bacterial, fungal and viral infections) [23], promot-
ing the growth rate of animals, raising immune 
functions, accelerating dioxin elimination, preven-
ting the stress-included ulcers, greatly decreasing 
the high fat diet induced dyslipidemia, improvement 
of diabetic hyperglycemia, and anti-inflammation 
property [24]. Based on these biological properties, 
C. vulgaris is commonly used in nutrition and in 
pharmaceutical and biomedicine research projects 
[9,25]. However, the biomass of C. vulgaris has a 
low protein digestibility due to its strong cell wall 
[26]; therefore, there is a need for digestibility 
improvement through cell wall disruption in order to 
be used in human foods and drugs [27]. 
The enzymatic hydrolysis of microalgal cell 
proteins has been described as a promising method 
for the improvement of protein digestibility because 
most microalgae are indigestible to monogastric 
animals and humans [25,28-30]. However, to our 
knowledge, no report is available in the scientific 
literature on the biological activity of the major 
proteins of C. vulgaris or their biopeptide hydro-
lysates. For this reason, the objective of the present 
research was to optimize the intracellular extraction 
of C. vulgaris proteins, and then to evaluate the 
effect of pepsin-hydrolyzed peptides on Escherichia 
coli and breast cancer cell lines aiming to introduce 
them as functional food ingredients. 
 
2. Materials and Methods 
2.1. Materials 
 
All chemicals used in this study were purchased 
from Sigma-Aldrich Chemie GmbH (Munich, 
Germany). Pepsin (EC number: 3.4.23.1. and ≥2500 
units per mg dry weight activity) was purchased 
from Worthington Biochemical Co. (Lakewood, NJ, 
USA). All solutions, prepared with double-distilled 
water, were kept at 4°C before further use. 
 
2.2. Microalgae, cultivation conditions and 
biomass processing 
 
The unicellular green algae C. vulgaris 211/11B 
was kindly provided by the Agricultural Biotechnol-
ogy Research Institute of Iran (ABRII), and was 
cultivated in 3N-BBM/vit medium (available at: 
http://www.ccap.ac.uk/). The inoculated flasks were 
incubated at 24°C under manual shaking and 
irradiated at 4000 Lux. The microalgae cells were 
collected at mid-log growth phase by centrifugation 
(1500 ×g at 15 min) and stored as pellets at -20°C.  
 
2.3. Protein extraction and purification 
 
Protein extraction started with suspending 5 g of 
frozen algal sample in 40 ml distilled water. The 
algal suspension was homogenized for 10 min in a 
mortar with liquid nitrogen using the following lysis 




lfonate), 40 mM Tris–base, 100 mM DTT 
(dithiothreitol) and 0.1 M PMSF [31]. The 
homogenized mixture was centrifuged at 9000 ×g 
for 30 min to separate the cell debris. Total proteins 
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contained in the supernatants were then precipitated 
by 50% w v
-1
 ammonium sulfate. 
Protein content determination was carried out 
using the Bradford method [32], which is a spectro-
photometric determination at 595 nm using 
Coomassie Blue G-250 as a protein binding dye. 
Bovine serum albumin (BSA) was used as standard 
protein. The protein composition of the algal 
extracts was visualized using SDS-PAGE (Bio-Rad 
Laboratories, CA, USA) according to the 
instructions of the manufacturer. Samples were 
prepared with 1:1 ratio of the supernatants and SDS 
sample buffer and ran at 120 V for 90 min. Gels 
with 10% concentration were stained with 
Coomassie Brilliant Blue R-250. 
HPLC analyses were carried out using HPLC-
UV equipment (KNUER, Germany) equipped with a 
Polaris C18 cartridge column. The flow rate and 
injection volume were 1 ml min
-1
 and 50 µl, 
respectively. The protein samples were filtered 
through a 0.2 µm filter before the HPLC analysis. 
Analyses of proteinaceous materials were performed 
in a gradient procedure method with acetonitrile and 
water as eluent that started with 10% acetonitrile 
and reached to 90% in 30 min. To investigate 
probably bonded pigments with the extracted 
protein, Photodiode Array (PDA) detector was used 
in the range of 200 to 600 nm. 
 
2.4. Preparation of hydrolysate peptides 
 
Pepsin hydrolysates were prepared in simulated 
human gastric conditions as follows: the separated 
protein was digested by pepsin using an enzyme to 
substrate the ratio of 2% w w
-1
 at pH 2.0, at 37°C 
for 15 h. The digestion was adjusted to pH 7.0 and 
heated in a boiling water bath for 10 min at the end 
of the reaction to inactivate the enzyme. To remove 
the enzyme, the hydrolysates were centrifuged at 
4000 ×g for 15 min and were then filtered through a 
membrane with a pore diameter of 0.2 μm. 
The enzymatic hydrolysates obtained under the 
above mentioned conditions were ultrafiltered using 
Amicon 10, 5 and 3 kDa molecular weight cutoff 
(MWCO) membranes, respectively (Billerica, MA, 
USA). The fractions [smaller than 3 (<3) kDa, in the 
range of 3 to 5 (3–5) kDa, in the range of 5 to 10 (5-
10) kDa, and higher than 10 (>10 kDa)] were 
collected, and their antimicrobial and antitumor 
activities were measured. 
 
2.5. Determination of peptide concentration 
 
Spectrophotometric assay using ophthaldiald-
ehyde (OPA) was used for the determination of the 
proteolysis degree [33]. A fresh OPA solution was 
prepared daily with 25 ml of 100 mM sodium tetra 
hydroborate, 2.5 ml of 20% SDS solution (w w
-1
), 1 
ml of OPA reagent (40 mg OPA in 1 ml methanol) 
and 100 µl of β-mercaptoethanol and adjusted to 50 
ml with distilled water. 100 µl of the samples 
together with 1 ml of OPA solution were added to 
the test tube and after 2 min, the reading with 
spectrophotometer was performed at 340 nm using 
distilled water as control. 
 
2.6. Determination of antibacterial properties 
 
Antibacterial activity of each protein fraction 
was investigated to select for the next stage of the 
experiments the fraction displaying the maximum 
antibacterial activity. Antibacterial activity of the 
peptide fractions was determined against E. coli 
CECT 434. For this purpose, E. coli was cultured in 
Liquid broth medium (10 g l
-1
 Tryptone, 10 g l
-1
 
NaCl, 5 g l
-1
 Yeast Extract) for 16 h at 37°C. 50 µl 
of each fraction sample was added to 200 µl of the 
bacterial culture and incubated at 37°C with 
shaking. The inhibitory effect was measured at 
regular time intervals based on optical density at 
600 nm. 
 
2.7. Cell culture 
 
Human breast adenocarcinoma cell lines (MCF-7 
cell line) were seeded in appropriate culture medium 
(RPMI 1640, 10% FBS, 1% Pen/Strep). The cells 
were plated at a density of 10
4 
cells/well in a 96-well 
microtiter plate overnight. Tissue culture plates were 
incubated at 37°C in humidified 5% CO2 atmos-
phere. 
 
2.8. MTT assay 
 
Cytotoxic levels of the peptide fractions in the 
cultured MCF-7 breast cancer cells were measured 
using [3-(4,5-dimethyl thiazole-2-yl)]c-2,5-diphenyl 
tetrazolium bromide (MTT, Sigma-Aldrich)-based 
cell titer assay [34]. The cells were allowed to attach 
and grow for 36 h. The old medium was then 
replaced with a fresh medium and treated with 
varying concentrations of peptide fractions (0-160 
µg ml
-1
). Each sample was added into the wells to 
determine the effect on growth according to the time 
and concentration. MTT dye was added after each 
time-point followed by the determination of the 
formation of colored formazan product by a 
detergent solution. The plate was read at 570 nm in 
a TECAN Micro plate Reader (Infinite® 200 PRO 
series, Männedorf, Switzerland). For control, 
appropriate row or column of wells was left 
untreated at each time point. The hydrolysate 
concentration, which gives 50% growth inhibition, 
is referred to as the IC50. A simple method for 
calculation of the IC50 (Eq. 1) is performed by linear 
interpolation between the concentrations above and 
beneath 50% inhibition in the dose response curve 
(= two flanking points) that is calculated as follows: 
             (  (         )  
 (
(             )
(                     )
    
        
        
))       Eq. 1  
 
Where, conc is the effective concentration of the 
desired fraction, and signal is related to the 
inhibition value of the considered sample. 
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2.9. Statistical analysis 
 
Experimental data were analyzed using the 
SPSS16.0 software (SPSS, Chicago, IL, USA) with 
sample means and standard errors of 10%. All tests 
were conducted in triplicate. Experimental data were 
expressed as mean±standard deviation. 
 
3. Results and Discussion 
3.3. Optimum protein extraction method 
 
Culturing of microalgae was carried out by auto-
trophic outdoor cultivation of C. vulgaris at room 
temperature with shaking system. The high protein 
content (>50% of biomass) of C. vulgaris was one 
of the reasons for selecting this organism as an 
unconventional protein source. To extract the whole 
protein, several methods were examined, including 
homogenization, sonication and glass beads for cell 
wall disruption and achieving maximum number of 
protein fractions extraction. According to the protein 
concentration, as well as the SDS-PAGE and HPLC 
results, among the tested methods, maximum 
protein fractions were obtained with liquid nitrogen 
and lysis buffer extraction method (data not shown). 
Among the protein fractions obtained, the 
fraction with 62 kDa molecular weight had the 
highest concentration. Figure 1 shows the SDS-
PAGE gel (Fig. 1a) and HPLC chromatogram (Fig. 
1b) of the selected protein bonds among several 
proteins. The HPLC chromatogram confirmed the 
above results, and scanning in the 200-600 nm wave 
length range demonstrated that no pigment was 
bonded to the protein (Fig. 1c). Therefore, this 
extraction method proved to be a rapid, simple and 
efficient approach to isolate the highest con-
centration of C. vulgaris protein fractions. 
 
3.4. Enzymatic hydrolysis of the extracted 
protein 
 
In order to simulate human gastric conditions, 
this study utilized pepsin for protein hydrolysis at 
pH 2.0 and a temperature of 37°C for 15 h of 
digestion time. This experiment is based on 62 kDa 
protein, the most abundant protein fraction in the 
whole protein profile. This hydrolysate had peptides 
of various size ranges, differentiated as follows: <3 
kDa, 3-5 kDa, 5-10 kDa and >10 kDa, and their 
impact on cell viability was determined. The degree 
of hydrolysis measured by the OPA method was 
increased to 2000 µg ml
-1
 for all fractions. Optimal 
concentration of the efficient peptide fractions was 
determined by examining the impact on cells of 





3.5. Cytotoxic activity of the hydrolyzed peptide 
fractions 
 
High sensitivity and stability are among the 
characteristics that have made anticancer and anti-
microbial peptides very interesting topics for resear-
chers. Animal and plant food proteins have been 
regarded as main sources of bioactive peptides [35]. 
Generating bioactive peptides from foods has been 
the subject of many researches in recent years [36]. 
Some marine fish species like salmon, oyster, 
macroalgae, squid, sea urchin, shrimp, snow crab, 
and seahorse have also been used as sources of 
bioactive peptides [35]. Based on previous studies, 
potent biological activities (i.e., antihypertensive, 
antioxidant, immunomodulatory, anticancer, antim-
icrobial, and lipid lowering activities) have been 
shown by protein hydrolysates. 
The selected protein was hydrolyzed with pepsin 
under gastric medium conditions, and the hydro-
lysed peptides were separated according to their 
molecular weight as follows: <3, 3–5, 5–10 and >10 
kDa. To meet the aim of this study, the antibacterial 
properties of peptides were investigated on E. coli 
and the results were also compared to the 
antibacterial properties of the whole C. vulgaris 
biomass and 62 kDa protein. As shown in Fig. 2, the 
hydrolysed peptides have the highest inhibitory 
effect of 34.1% on E. coli following 16 h of 
incubation. It is worth noting that both the C. 
vulgaris biomass and the 62 kDa protein inhibited 
bacterial growth to a certain extent. The comparison 
between proteins and their hydrolysate peptides 
suggests the significant role of bioactive peptides, 
which can be, therefore, considered as latent factors 
in parent proteins before hydrolysis. The percent-
ages of inhibition, shown in Table 1, indicate that 
the effect of hydrolysate peptides was 8.5 and 1.6 
times greater than that of the Chlorella biomass and 
its proteins, respectively, suggesting that the pept-
ides effectively induced the cell wall destruction of 
E. coli and inhibited the growth of cells. 
 
Table 1. Inhibitory effect of C. vulgaris biomass, its 
purified proteins and produced bioactive peptides on E. 
coli 
 
Inhibitory effect (%) Test material 
0 Control* 
4.0 Chlorella biomass 
21.2 Proteins 
34.1 Bioactive peptides 
* E. coli grown in pure culture medium 
 
Antimicrobial assay between the extracted 
protein and the peptides was done without fraction-
ation because it was necessary to make a distinction 
between these two samples for their potential of 
growth inhibition, and to find out if there are some 
peptides in parent protein that act just with hydrol-
ysis. Actually, it was an initial test to make sure if 
the produced peptides have a nutraceutical effect. 
Because of the side effects of cancer treatment, 
alternative procedures such as the use of antimic-
robial peptides are investigated. Some studies have 
shown antimicrobial peptides to be cytotoxic for 
cancer cells and to be able to prevent their undesired 
and uncontrolled growth [37]; for this reason, anti-
microbial peptides are regarded as new antibiotics  
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Figure 1. Analysis of the extracted protein fraction: a) SDS-PAGE profile of selected protein inside the ladder sample, b) 
HPLC chromatogram in 218 (black), 230 (red) and 280 (green) nm, and c) scanning in the 200-600 nm wavelength range to 
assess lack of pigments. 
 
 
having strong antimicrobial properties, and are adm-
inistered against antibiotic resistant bacteria [38]. 
To compare the anticancer properties of peptide 
fractions with those of the C. vulgaris biomass and 
the 62 kDa protein, the effect of all samples on 
MCF-7 cell line at a given concentration of 2 μg μl
-1
 
was examined for 24, 48 and 72 h. As shown in Fig. 
3, the results indicated a dose- and time-dependent 
inhibition in the growth of MCF-7 cells. At a 
concentration of 160 μg μl
-1
, the 3-5 KDa peptide 
fractions showed the highest inhibitory effect on 
MCF-7 cells, with a cell growth reduction of over 
60% after 72 h of incubation. As it is obvious in Fig. 
3, there is a significant difference between the biom-
ass effect and the peptide fractions on the cells. 
However, the inhibitory effect of the parent protein 
had little difference with the peptide fractions due to 
the existence of peptides in the extracted protein 
sequences with less effect than released peptides. 
So, to reach more inhibition on the growth of cancer 
cells, it was necessary to hydrolyze the extracted 
protein and find the efficient peptide fractions IC50 
is a good measure of the inhibitory effect of drugs. 
As shown in Figures 3 and 4, the 3-5 kDa bioactive 
peptides (50 μg μl
-1
) were capable of reducing cell 
viability by 50% after 72 h. In contrast, treatments 
with the 3-5 kDa fractions at 24 h time-point revea-
led negligible inhibition of the growth of MCF-7 
cells compared to the untreated cells (Figure 3). For 
48 h time-point, the inhibitory effect was pronoun-
ced, even if the IC50 was not reached. It was also 
observed that both 48 and 72 h time-points showed 
similar values at concentrations below 10 μg μl
-1
 
whereas higher decreases were observed for the 72 h 
time-point at concentrations above 10 μg μl
-1
.  
Wang et al. reported that enzymatic hydrolysates 
from different soy varieties inhibited the viability of 
cultured leukemia cells with the IC50 values of 3.5 to 
6.2 mg ml
-1
, which were significantly lower than the 
activity of lunasin (a well-known protein derived 
peptide in soy) with the IC50 value of 0.078 mg ml
-1
 
[39]. Recent studies have shown that low molecular 
size peptides from Pacific oyster hydrolysates have 
induced the dose-dependent growth inhibition of 
transplanted murine sarcoma in BALB/c mice possi-
bly via increased immune stimulation [35]. 
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Figure 2. E. coli growth curve for determination of the antimicrobial activity of C. vulgaris biomass, 62 kDa protein and 
bioactive peptides compared to a control culture (all experiments were carried out in triplicate). 
 
Diverse molecules with pharmacological poten-
tial are found in plants. For example, thonins that 
are small cysteine rich peptides (˜5 kDa) with toxic 
and antimicrobial properties were the first AMP 
isolated from plants. Cytotoxic and anticancer activ-
ities are shown by several plant thionins, e.g., pyrul-
aria thionin from mistletoe (Pyrularia pubera) with 
an IC50 of 50 μg μl
-1
 against the cervical cancer cells 
(HeLa) and mouse melanoma cells (B16). Poor 
stability and susceptibility to proteolytic digestion 
are some of the problems that must be solved in 
future [40]. Colon and breast anticancer effects of 
peptide hydrolysates derived from rice bran were 
shown by Kannan et al. With an IC50 of 770 μg μl
-1
, 
the <5 kDa peptide fraction separated from rice bran 
protein hydrolysate demonstrated a potent antitumor 
activity against cancer cells [41]. 
However, few publications have studied the anti-
cancer activities of marine proteins. Significant 
growth inhibitors on MCF-7/6 and MDA-MB-231 
cell lines were found to be from three blue whiting, 
three cod, three plaice and one salmon hydrolysate. 
They contained a complex mixture of free amino 
acids and peptides of various sizes ranging up to 7 
kDa, based on the composition analysis [42]. In 
order to produce bioactive hydrolysates, seven com-
mercial proteases (Protamex, Trypsin, Neutrase, 
Savinase, NS37005, Esperase and Alcalase) were 
also used to hydrolyze gelatin obtained from giant 
squid (Dosidicus gigas) inner and outer tunics. The 
most potent angiotensin-converting enzyme inhibi-
tor was Alcalase hydrolysate (IC50 = 0.34 mg ml
-1
) 
while the highest cytotoxic effect on cancer cells 
was shown by Esperase hydrolysate with the IC50 
values of 0.13 and 0.10 mg ml
-1
 for MCF-7 and U87 
(glioma) cell lines, respectively [43]. 
Recently, great interest has been shown for 
microalgal proteins as sources of bioactive peptides 
because of their therapeutic potential in the 
treatment of various diseases. Peptides are released 
from the parent proteins by the action of an enzyme 
(usually a protease); when consumed as pure pept-
ides or hydrolysates, they can exert their function by 
modulating the structure and function of metabolic 
enzymes, implicated in certain diseases, after absor-
ption into the blood circulatory system. In this 
research, C. vulgaris was introduced as a source of 
bioactive peptides to be used as functional food 
ingredients or pharmaceutical products with antib-
acterial and anticancer effects. 
Several pharmaceutical actions of enzymatic 
protein hydrolysates from C. vulgaris have been 
investigated, and the inhibition of angiotensin-
converting enzyme, the antioxidant functionality 
and the hypocholesterolemic effects have been the 
most studied. Additionally, different peptides from 
various sources exhibit an anticancer activity; there-
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Figure 3. Comparison of various samples (i.e., C. vulgaris biomass, extracted protein and produced bioactive 
peptides) at different concentrations for their anti-proliferative effect on MCF-7 cell line (all experiments carried 
out in triplicate). 
 
Figure 4. MTT assay for determination of the anti-proliferative activity of 3-5 kDa fractions at 48 and 72 h time-points with 
MCF-7 cells. Red line shows peptide concentration with 50% inhibition activity (IC50) for 72 h, and black line characterizes 
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of cancer through nutritional interventions. Sheih et 
al. reported the anticancer and antioxidant activities 
of peptides from C. vulgaris protein waste [22,25]. 
In their research, the peptides were isolated from the 
pepsin hydrolysate of algal protein waste, and 
among these peptides, a potent anti-proliferative, 
antioxidant and NO-production inhibiting peptide 
was introduced. They studied the anticancer effect 
of C. vulgaris protein waste hydrolysates on the 
AGS cell line in which the peptide fraction showed 
a dose dependent growth inhibitory effect on the 







In the present study, a protein extracted from C. 
vulgaris with biological activity and without an 
intense color and taste was chosen. Because the 
absorption span of microalgae pigments is in the 
visible spectrum, the absorption of the effective 
protein fraction was evaluated in the wavelength 
range of 200-600 nm, and no peak was observed. 
This finding appears to be helpful to ascribe 
anticancer activity to proteins without any additional 
materials. Finally, the protein extracted was cleaved 
to bioactive peptides through proteolysis by pepsin. 
Enzymatic hydrolysis of the proteins was done by 
pepsin in simulated human gastric media. Since the 
literature dealing with the digestibility of C. vulgaris 
proteins remains scarce, it was necessary to 
investigate and characterize hydrolysis of the 
selected protein. To simulate the gastric conditions, 
pepsin was used for protein hydrolysis. Some 
microalgae have shown potent cytotoxic activities, 
and polysaccharides and terpenoids are considered 
as contributing factors for anticancer effects among 
those. To the best of our knowledge, there has been 
no study on anticancer peptides from microalgae 
protein, and this is the first report on MCF-7 cell 
inhibition by peptides from C. vulgaris abundant 
protein. 
The intensification in the production of func-
tional foods supplemented with bioactive molecules 
such as carbohydrates, lipids, proteins and caroten-
oids produced by microalgae is a consequence of the 
growing need for people to improve their nutritional 
status because of the rhythm of modern life. As 
shown in this study, algal soluble proteins were 
extracted from C. vulgaris in an effective and 
efficient way to produce food ingredients. The 
results suggest that enzymatic protein hydrolysates 
from C. vulgaris could reduce cancer cell viability. 
In recent years, microalgae have been introduced as 
a functional food. Our study indicated that at least 
one protein in C. vulgaris produces hydrolysate 
peptides with antibacterial and anticancer function-
ality under gastric conditions by pepsin hydrolysis. 
The peptide fractions that demonstrate anticancer 
activities have the potential for use as functional 
food ingredients for health benefits. However, 
preparing cancer therapeutics is limited to ‘‘proof of 
concept’’ studies, and a long road lies ahead to the 
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